Use of RNA interference libraries to investigate oncogenic signalling in mammalian cells

被引:42
作者
Downward, J [1 ]
机构
[1] Canc Res UK London Res Inst, London WC2A 3PX, England
关键词
RNA interference; screening; transformation; library; oncogenesis;
D O I
10.1038/sj.onc.1208073
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Over the past decade, 'RNA interference' has emerged as a natural mechanism of silencing of gene expression. This ancient cellular antiviral response can be manipulated to provide an effective research tool to knock down the level of expression of selected target genes, providing a very powerful new method for the analysis of cell signalling pathways. Systematic silencing of genes on a genome-wide scale using large rationally designed libraries targeting many thousands of genes provides a novel functional genomics approach to the investigation of many aspects of mammalian cell behaviour, including oncogenic transformation. Here, the different approaches taken to use RNA interference libraries to study the cancer phenotype will be considered, including both selective and high throughput screens and the use of both vector-based and synthetic oligonucleotide-based methods for inducing RNA interference. The advantages and drawbacks of the competing methodologies will be discussed. RNA interference library technology holds great promise for enabling somatic cell genetics in tissue culture systems. Whether it can provide significant new insights into cancer will be its greatest challenge.
引用
收藏
页码:8376 / 8383
页数:8
相关论文
共 37 条
[1]   Lentiviral-mediated RNA interference [J].
Abbas-Terki, T ;
Blanco-Bose, W ;
Déglon, N ;
Pralong, W ;
Aebischer, P .
HUMAN GENE THERAPY, 2002, 13 (18) :2197-2201
[2]   Adenoviral vectors expressing siRNAs for discovery and validation of gene function [J].
Arts, GJ ;
Langemeijer, E ;
Tissingh, R ;
Ma, LB ;
Pavliska, H ;
Dokic, K ;
Dooijes, R ;
Misic, E ;
Clasen, R ;
Michiels, F ;
van der Schueren, J ;
Lambrecht, M ;
Herman, S ;
Brys, R ;
Thys, K ;
Hoffmann, M ;
Tomme, P ;
van Es, H .
GENOME RESEARCH, 2003, 13 (10) :2325-2332
[3]   Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening [J].
Aza-Blanc, P ;
Cooper, CL ;
Wagner, K ;
Batalov, S ;
Deveraux, QL ;
Cooke, MP .
MOLECULAR CELL, 2003, 12 (03) :627-637
[4]   A large-scale RNAi screen in human cells identifies new components of the p53 pathway [J].
Berns, K ;
Hijmans, EM ;
Mullenders, J ;
Brummelkamp, TR ;
Velds, A ;
Heimerikx, M ;
Kerkhoven, RM ;
Madiredjo, M ;
Nijkamp, W ;
Weigelt, B ;
Agami, R ;
Ge, W ;
Cavet, G ;
Linsley, PS ;
Beijersbergen, RL ;
Bernards, R .
NATURE, 2004, 428 (6981) :431-437
[5]   Induction of an interferon response by RNAi vectors in mammalian cells [J].
Bridge, AJ ;
Pebernard, S ;
Ducraux, A ;
Nicoulaz, AL ;
Iggo, R .
NATURE GENETICS, 2003, 34 (03) :263-264
[6]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[7]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[8]   Innovation - New tools for functional mammalian cancer genetics [J].
Brummelkamp, TR ;
Bernards, R .
NATURE REVIEWS CANCER, 2003, 3 (10) :781-789
[9]   Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB [J].
Brummelkamp, TR ;
Nijman, SMB ;
Dirac, AMG ;
Bernards, R .
NATURE, 2003, 424 (6950) :797-801
[10]  
Chen YC, 2003, CANCER RES, V63, P4801